These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31639685)

  • 1. Validation of the Procalcitonin Assay on the Abbott Architect i1000.
    Pagaduan JV; Tam E; Devaraj S
    J Appl Lab Med; 2019 May; 3(6):936-942. PubMed ID: 31639685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB; Hayden J; Colby JM
    Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.
    Walker C; Shuster A; Weber C; Gebhardt K; Scheidegger M; Swartzwelder J; Williams J; Li J
    Ann Clin Lab Sci; 2021 Mar; 51(2):241-244. PubMed ID: 33941564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.
    Soh A; Binder L; Clough M; Hernandez MH; Lefèvre G; Mostert K; Nguyen TB; Otte KM; Portakal O; Sandri MS; Yen JL; Huang J; Beshiri A
    Pract Lab Med; 2018 Nov; 12():e00110. PubMed ID: 30519621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A; Rotaru I; Beaudeux JL; Hennequin C
    Ann Biol Clin (Paris); 2018 Jun; 76(3):308-312. PubMed ID: 29622524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method Verification Shows a Negative Bias between 2 Procalcitonin Methods at Medical Decision Concentrations.
    Gruzdys V; Cahoon K; Pearson L; Lehman CM
    J Appl Lab Med; 2019 Jul; 4(1):69-77. PubMed ID: 31639709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. As a Novel Procalcitonin Assay is Architect B∙R∙A∙H∙M∙S PCT; Comparison of Two Commercial Systems.
    Aydemir Ö; Karakeçe E; Köroğlu M; Aydemir Y; Terzi HA; Erkorkmaz Ü; Altindiş M
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical and clinical performance of the Advansure i3 procalcitonin assay.
    Heo W; Park HD
    Scand J Clin Lab Invest; 2021 Nov; 81(7):546-551. PubMed ID: 34601986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M; Guido L; Micca G; Pittalis S; Locatelli M; Motta A; Bianchi V; Callegari T; Aloe R; Da Rin G; Lippi G
    Pract Lab Med; 2015 Aug; 2():22-28. PubMed ID: 28932801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Lo Cascio C; Demonte D; Faggian D; Plebani M
    Clin Chem Lab Med; 2019 Dec; 58(1):77-84. PubMed ID: 31539351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the procalcitonin (PCT) assay: Experience in a pediatric hospital.
    Agarwal S; Akbas N; Soundar EP; Gonzalez G; Devaraj S
    Clin Biochem; 2015 Sep; 48(13-14):886-90. PubMed ID: 25895483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of magnetic particle-based chemiluminescence immunoassay for measurement of human procalcitonin in serum.
    Liao M; Zheng J; Xu Y; Qiu Y; Xia C; Zhong Z; Liu L; Liu H; Liu R; Liang S
    J Immunol Methods; 2021 Jan; 488():112913. PubMed ID: 33189726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance characteristics of the ARCHITECT Galectin-3 assay.
    La'ulu SL; Apple FS; Murakami MM; Ler R; Roberts WL; Straseski JA
    Clin Biochem; 2013 Jan; 46(1-2):119-22. PubMed ID: 23010446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.
    Wang G; Wan Y; Lin G; Li Z; Dong Z; Liu T
    J Immunol Methods; 2020; 484-485():112829. PubMed ID: 32673618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays.
    Eidizadeh A; Wiederhold M; Schnelle M; Binder L
    Pract Lab Med; 2022 May; 30():e00274. PubMed ID: 35465623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W; Krassler J; Zingler C; Pertschy A; Hentschel J; Gerhards-Reich C; Mack M; Demant T
    Clin Lab; 2003; 49(7-8):319-27. PubMed ID: 12908732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples.
    Garrigan C; Han J; Tolomeo P; Johnson KJ; Master SR; Lautenbach E; Nachamkin I
    Am J Transl Res; 2016; 8(10):4362-4369. PubMed ID: 27830020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.